Table 2 Sensitivity analysis for the meta-analysis
Outcomes | No. of studies | MD(95% CI) | Heterogeneity test | ||
|---|---|---|---|---|---|
P | I2 (%) | ||||
KOA progress with CRP | All studies | 5 | 0.09 [−0.30, 0.13] | < 0.00001 | 93.0 |
Haghighian, 2014 | 4 | 0.07 [− 0.04, 0.18] | 0.02 | 70.0 | |
Hosnijeh, 2016 | 4 | −0.15 [− 0.77, 0.47] | < 0.00001 | 94.0 | |
Ramirez, 2014 | 4 | −0.07 [− 0.29, 0.16] | < 0.00001 | 94.0 | |
Scorei, 2011 | 4 | −0.15 [− 0.78, 0.49] | < 0.00001 | 94.0 | |
Zhang, 2015 | 4 | −0.20 [− 0.42, 0.02] | < 0.00001 | 93.0 | |
KOA incidence with CRP | All studies | 4 | 0.33 [0.04, 0.63] | < 0.00001 | 96.0 |
Engstrom, 2009 | 3 | 0.39 [−0.08, 0.86] | < 0.00001 | 97.0 | |
Hosnijeh, 2016 | 3 | 0.45 [−0.05, 0.95] | < 0.00001 | 97.0 | |
Kerkhof, 2010 | 3 | 0.46 [0.06, 0.86] | < 0.00001 | 97.0 | |
Zhang, 2015 | 3 | 0.09 [−0.03, 0.21] | 0.01 | 76.0 | |
KOA pain with CRP | All studies | 3 | 1.60 [0.52, 2.67] | 0.001 | 85.0 |
Nielsen, 2014 | 2 | 1.69 [−0.02, 3.40] | 0.03 | 78.0 | |
Sowers, 2002 | 2 | 1.13 [0.44, 1.82] | 0.49 | 0.0 | |
Stannus, 2012 | 2 | 1.88 [0.76, 3.00] | 0.003 | 89.0 | |